|
US10441654B2
(en)
|
2014-01-24 |
2019-10-15 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
SMC combination therapy for the treatment of cancer
|
|
US9732154B2
(en)
|
2014-02-28 |
2017-08-15 |
Janssen Biotech, Inc. |
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
|
|
US9603927B2
(en)
|
2014-02-28 |
2017-03-28 |
Janssen Biotech, Inc. |
Combination therapies with anti-CD38 antibodies
|
|
JP6707531B2
(ja)
|
2014-09-09 |
2020-06-10 |
ヤンセン バイオテツク，インコーポレーテツド |
抗ｃｄ３８抗体による併用療法
|
|
TWI721959B
(zh)
|
2014-12-04 |
2021-03-21 |
美商健生生物科技公司 |
治療急性骨髓性白血病之抗ｃｄ３８抗體
|
|
MX389805B
(es)
|
2015-05-20 |
2025-03-11 |
Janssen Biotech Inc |
Anticuerpos anti-cd38 para el tratamiento de amiloidosis de cadena ligera y otras enfermedades malignas hematológicas positivas para cd38.
|
|
NZ777133A
(en)
|
2015-06-22 |
2025-05-02 |
Janssen Biotech Inc |
Combination therapies for heme malignancies with anti-cd38 antibodies and survivin inhibitors
|
|
US20170044265A1
(en)
|
2015-06-24 |
2017-02-16 |
Janssen Biotech, Inc. |
Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38
|
|
US20160376373A1
(en)
*
|
2015-06-24 |
2016-12-29 |
Janssen Biotech, Inc. |
Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38
|
|
HK1248115A1
(zh)
*
|
2015-07-16 |
2018-10-12 |
Bioxcel Therapeutics, Inc. |
一种使用免疫调节治疗癌症的新颖方法
|
|
SMT202100192T1
(it)
|
2015-11-03 |
2021-05-07 |
Janssen Biotech Inc |
Formulazioni sottocutanee di anticorpi anti-cd38 e loro usi.
|
|
US10781261B2
(en)
|
2015-11-03 |
2020-09-22 |
Janssen Biotech, Inc. |
Subcutaneous formulations of anti-CD38 antibodies and their uses
|
|
WO2017160954A1
(en)
|
2016-03-15 |
2017-09-21 |
Seattle Genetics, Inc. |
Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors
|
|
EP3463463A4
(en)
|
2016-06-03 |
2020-01-15 |
Seattle Genetics, Inc. |
Combination of cd33 antibody drug conjugates with chemotherapeutic agents
|
|
WO2017214433A1
(en)
|
2016-06-09 |
2017-12-14 |
Seattle Genetics, Inc. |
Combinations of pbd-based antibody drug conjugates with flt3 inhibitors
|
|
AU2018359527A1
(en)
|
2017-10-31 |
2020-05-07 |
Janssen Biotech, Inc. |
Methods of treating high risk multiple myeloma
|
|
WO2021138407A2
(en)
|
2020-01-03 |
2021-07-08 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to cd33 and uses thereof
|
|
US11963683B2
(en)
|
2020-10-02 |
2024-04-23 |
Cilag Gmbh International |
Method for operating tiered operation modes in a surgical system
|
|
US12213801B2
(en)
|
2020-10-02 |
2025-02-04 |
Cilag Gmbh International |
Surgical visualization and particle trend analysis system
|
|
US11830602B2
(en)
|
2020-10-02 |
2023-11-28 |
Cilag Gmbh International |
Surgical hub having variable interconnectivity capabilities
|
|
US11992372B2
(en)
|
2020-10-02 |
2024-05-28 |
Cilag Gmbh International |
Cooperative surgical displays
|
|
US12064293B2
(en)
|
2020-10-02 |
2024-08-20 |
Cilag Gmbh International |
Field programmable surgical visualization system
|
|
US11672534B2
(en)
|
2020-10-02 |
2023-06-13 |
Cilag Gmbh International |
Communication capability of a smart stapler
|
|
US11877897B2
(en)
|
2020-10-02 |
2024-01-23 |
Cilag Gmbh International |
Situational awareness of instruments location and individualization of users to control displays
|
|
US12472032B2
(en)
|
2020-10-02 |
2025-11-18 |
Cilag Gmbh International |
Monitoring of user visual gaze to control which display system displays the primary information
|
|
US12016566B2
(en)
|
2020-10-02 |
2024-06-25 |
Cilag Gmbh International |
Surgical instrument with adaptive function controls
|
|
US11748924B2
(en)
|
2020-10-02 |
2023-09-05 |
Cilag Gmbh International |
Tiered system display control based on capacity and user operation
|
|
US12484897B2
(en)
|
2020-10-02 |
2025-12-02 |
Cilag Gmbh International |
Surgical instrument with adaptive configuration control
|
|
CN116948029A
(zh)
|
2022-04-20 |
2023-10-27 |
南京融捷康生物科技有限公司 |
一种包含IgG类Fc区变体的抗体及其用途
|